-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD) is a chronic inflammatory disease, mainly including Crohn's disease (CD) and ulcerative colitis (UC)
.
The incidence of IBD in Greece is approximately 10 per 100,000 inhabitants per year (6.
Inflammatory bowel disease (IBD) is a chronic inflammatory disease, mainly including Crohn's disease (CD) and ulcerative colitis (UC)
The study was conducted at 17 IBD referral centers in Greece
.
Researchers retrospectively collected and analyzed the demographic, clinical, laboratory, IBD, and anemia treatment data of the included patients
A total of 1394 IBD patients were recruited for this study [560 ulcerative colitis (UC), 834 Crohn's disease (CD)]
.
687 (49.
diagnosis
This study found that the frequency of anemia in IBD patients is approximately 50%
.
The development of recurrent/persistent anemia can be observed in 20% of cases and is independently related to extraintestinal manifestations, IBD duration, IBD-related surgery, and hospitalization
This study found that the frequency of anemia in IBD patients is approximately 50%
Original source:
Kalliopi Foteinogiannopoulou.
The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study.
Leave a message here